Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week
March 11, 2024 at 14:29 PM EDT
The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|